Cabello, P.; Torres-Ruiz, S.; Adam-Artigues, A.; Forés-Martos, J.; MartÃnez, M.T.; Hernando, C.; Zazo, S.; Madoz-Gúrpide, J.; Rovira, A.; Burgués, O.;
et al. miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer. Cancers 2023, 15, 2138.
https://doi.org/10.3390/cancers15072138
AMA Style
Cabello P, Torres-Ruiz S, Adam-Artigues A, Forés-Martos J, MartÃnez MT, Hernando C, Zazo S, Madoz-Gúrpide J, Rovira A, Burgués O,
et al. miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer. Cancers. 2023; 15(7):2138.
https://doi.org/10.3390/cancers15072138
Chicago/Turabian Style
Cabello, Paula, Sandra Torres-Ruiz, Anna Adam-Artigues, Jaume Forés-Martos, MarÃa Teresa MartÃnez, Cristina Hernando, Sandra Zazo, Juan Madoz-Gúrpide, Ana Rovira, Octavio Burgués,
and et al. 2023. "miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer" Cancers 15, no. 7: 2138.
https://doi.org/10.3390/cancers15072138
APA Style
Cabello, P., Torres-Ruiz, S., Adam-Artigues, A., Forés-Martos, J., MartÃnez, M. T., Hernando, C., Zazo, S., Madoz-Gúrpide, J., Rovira, A., Burgués, O., Rojo, F., Albanell, J., Lluch, A., Bermejo, B., Cejalvo, J. M., & Eroles, P.
(2023). miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer. Cancers, 15(7), 2138.
https://doi.org/10.3390/cancers15072138